Tradestie Institutional Equity Comparison Engine
SNDX vs NUVB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NUVB Overall Edge
NUVB Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuvation Bio Inc. (NUVB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SNDX trades at N/M Forward P/E with -61.7% operating margin (+81.6% YoY revenue) versus NUVB at N/M Forward P/E and -61.2% operating margin (+242.6% YoY). In options structure, SNDX sits in BREAKDOWN (41st %ile IV; Dealer Gamma Walls on Pro) against NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SNDX N/M vs NUVB N/M Fwd P/E
Growth & Margin Winner
NUVB
Op Margin -61.7% vs -61.2% ยท YoY +81.6% vs +242.6%
Momentum & Technical Winner
NUVB
1Y -47.8% vs -46.9% ยท 52W Pos 2% vs 2%
Options & Structure Winner
NUVB
BREAKDOWN (41st %ile IV) vs BREAKDOWN (26th %ile IV)
SNDX
NASDAQ
Syndax Pharmaceuticals, Inc.
Pharmaceutical Preparations
$8.72
-4.49% 1D
Market Cap
$822.0M
1M Return
-35.74%
1Y Return
-47.82%
Forward P/E
N/M
Unified AI Score
63.9 / 100
BUY
Tech 60.0
Fund 61.0
Flow 67.0
Mom 55.0
NUVB
NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap
$1.3B
1M Return
-19.15%
1Y Return
-46.85%
Forward P/E
N/M
Unified AI Score
61.0 / 100
BUY
Tech 53.0
Fund 61.0
Flow 67.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SNDX -47.82%
NUVB -46.85%
Spread: +0.97 pp (NUVB Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SNDX Revenue | NUVB Revenue | SNDX Op. Margin | NUVB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2016 | $0M | N/A | -3587.4% | N/A | SNDX |
| FY2017 | $0M | N/A | -2939.0% | N/A | SNDX |
| FY2018 | $0M | N/A | -5001.7% | N/A | SNDX |
| FY2019 | $0M | N/A | -3792.9% | N/A | SNDX |
| FY2020 | $0M | N/A | -4708.2% | N/A | SNDX |
| FY2021 | $140M | N/A | 18.8% | N/A | SNDX |
| FY2024 | $20M | $10M | -1434.4% | -7527.3% | SNDX |
| FY2025 | $170M | $60M | -158.4% | -338.7% | SNDX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SNDX | NUVB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $822.0M | $1.3B | Larger Scale | NUVB |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +81.6% | +242.6% | Higher Growth | NUVB |
| Operating Margin (TTM) Profitability | -61.7% | -61.2% | Higher Margin | NUVB |
| Net Profit Margin Profitability | -72.3% | -67.4% | Higher Margin | NUVB |
| Return on Equity (ROE) Capital Efficiency | -426.4% | -49.1% | Higher ROE | NUVB |
| 52-Week Range Position Momentum | 2% ($8โ$26) | 2% ($4โ$10) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 112% Vol | 1.52ฮฒ ยท 55% Vol | Lower Realized Risk | NUVB |
| Unified Institutional Score Composite Signal | 63.9 / 100 (BUY) | 61.0 / 100 (BUY) | Higher Composite | SNDX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SNDX vs NUVB Buy Guide
SNDX
BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
41st %ile
IV Regime
Balanced (25thโ60th %ile)
NUVB
BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
26th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SNDX nor NUVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.